Indoor residual spraying for preventing malaria (Publications)
the prevalence was reduced substantially over a period of 7 years (from 60 to 65% prevalence to 4 to 8% prevalence; the weighted PE before-after was 74% (95% CI 72 to 76%).Unstable malaria (EIR < 1): In
Drugs for treating <em>Schistosoma mansoni</em> infection (Publications)
placebo, oxamniquine 40 mg/kg probably reduces parasitological treatment failure at three months (RR 8.74, 95% CI 3.74 to 20.43, two trials, 82 participants, moderate quality evidence). Lower doses than
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial... (Publications)
(signatures 1 and 5) and a homologous recombination repair deficiency-like group (signatures 3 and 8), and chromothripsis was investigated using previously established criteria. Progression-free survival
Indoor residual spraying for preventing malaria (Publications)
the prevalence was reduced substantially over a period of 7 years (from 60 to 65% prevalence to 4 to 8% prevalence; the weighted PE before-after was 74% (95% CI 72 to 76%).Unstable malaria (EIR < 1): In
Drugs for treating <em>Schistosoma mansoni</em> infection (Publications)
placebo, oxamniquine 40 mg/kg probably reduces parasitological treatment failure at three months (RR 8.74, 95% CI 3.74 to 20.43, two trials, 82 participants, moderate quality evidence). Lower doses than
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial... (Publications)
(signatures 1 and 5) and a homologous recombination repair deficiency-like group (signatures 3 and 8), and chromothripsis was investigated using previously established criteria. Progression-free survival
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8(+) T cell responses post SARS-CoV-2 infection. Immunity . 2023;56(4):864-878 e4. DOI: 10.1016/j.immuni
A et al. Lung function-associated exposome profile in the era of climate change: pooled analysis of 8 population-based European cohorts within the EXPANSE project. Environ Int . 2025;196:109269. DOI: 10
sutezolid or delpazolid for the treatment of drug-susceptible TB. J Antimicrob Chemother . 2025;80(8):2305-2313. DOI: 10.1093/jac/dkaf210 Maghradze N et al. Linking genetic and phenotypic bedaquiline
ng der wichtigste Umweltrisikofaktor, verantwortlich für über 6,5 Millionen vorzeitige Todesfälle [8]. Die europäische Umweltagentur beziffert in ihrer Gesundheitsfolgenabschätzung für das Jahr 2018 die [...] Clean Air Act: Substantial Success and the Challenges Ahead. Ann Am Thorac Soc. 2018; 15(3): 296–7. [8] GBD Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories,
